The Role of a Prescription Drug Monitoring Program in Reducing Prescription Drug Diversion, Misuse, and Abuse
Provides facts about the benefits of using PDMPs for prescribers, pharmacists, patients, and regulatory and law enforcement agencies.
This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 [PDF 0.69 MB] and Volume 2 [PDF 1.28 MB] of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.
Provides facts about the benefits of using PDMPs for prescribers, pharmacists, patients, and regulatory and law enforcement agencies.
Describes how to more effectively and safely manage patients seeking care for acute pain and encourages the clinician to carefully consider unintended consequences (abuse, misuse, overdose, addiction, and diversion) when prescribing opioids.
Provides a template for an agreement that describes the patient's responsibilities and commitment not to engage in certain activities.
Provides clinical recommendations for initiating and maintaining chronic opioid therapy of 90 days or longer.
Assesses the evidence regarding the use and abuse of opioids by chronic noncancer pain patients to create a set of clinical practice guidelines for the responsible prescribing of opioids.
Provides information on the potential benefits and risks of opioid medications and documents that both the patient and provider agree on a care plan.
Describes best practices of routine urine drug testing as part of an overall treatment plan that includes chronic opioid prescribing.